Image-guided quantification of cardioplegia delivery during cardiac surgery

Heart Surgery Forum

Volumn 10, Issue 5, 2007, Pages 273-278

  Soltesz, Edward G ^a   Laurence, Rita G ^a   De Grand, Alec M ^b   Cohn, Lawrence H ^a   Mihaljevic, Tomislav ^a   Frangioni, John V ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; CARDIOPLEGIC AGENT; COLORING AGENT; DIAGNOSTIC AGENT;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BYPASS SURGERY; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART RIGHT VENTRICLE; HEART SURGERY; IMAGE ANALYSIS; MALE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NON INVASIVE MEASUREMENT; NONHUMAN; ONLINE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SWINE; VIDEODENSITOMETRY; ANIMAL; COMPUTER ASSISTED SURGERY; DIAGNOSTIC IMAGING; FEASIBILITY STUDY; FLUORESCENCE; METHODOLOGY; PEROPERATIVE CARE;

ANIMALS; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; COLORING AGENTS; DIAGNOSTIC IMAGING; FEASIBILITY STUDIES; FEMALE; FLUORESCENCE; INDOCYANINE GREEN; INTRAOPERATIVE CARE; MALE; SURGERY, COMPUTER-ASSISTED; SWINE;

EID: 35349020964     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20071099     Document Type: Article

References (20)

1. Aldea GS, Hou D, Fonger JD, Shemin RJ. 1994. Inhomogeneous and complementary antegrade and retrograde delivery of cardioplegic solution in the absence of coronary artery obstruction. J Thorac Cardiovasc Surg 107:499-504.
2. Aronson S, Lee BK, Liddicoat JR, et al. 1991. Assessment of retrograde cardioplegia distribution using contrast echocardiography. Ann Thorac Surg 52:810-4.
3. Balacumaraswami L, Abu-Omar Y, Choudhary B, et al. 2005. A comparison of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency. J Thorac Cardiovasc Surg 130:315-20.
4. De Grand AM, Frangioni JV. 2003. An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2:553-62.
5. Dearani JA, Axford TC, Patel MA, et al. 2001. Role of myocardial temperature measurement in monitoring the adequacy of myocardial protection during cardiac surgery. Ann Thorac Surg 72:S2235-43; discussion S2243-4, S2267-2270.
6. Garski TR, Staller BJ, Hepner G, et al. 1978. Adverse reactions after administration of indocyanine green. JAMA 240:635.
7. Hope-Ross M, Yannuzzi LA, Gragoudas ES, et al. 1994. Adverse reactions due to indocyanine green. Ophthalmology 101:529-33.
8. Khuri SF, Josa M, Marston W, et al. 1983. First report of intramyocardial pH in man. II. Assessment of adequacy of myocardial preservation. J Thorac Cardiovasc Surg 86:667-78.
9. Kim S, Lim YT, Soltesz EG, et al. 2004. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22:93-7.
10. Kumbhani DJ, Healey NA, Birjiniuk V, et al. 2004. Intraoperative regional myocardial acidosis predicts the need for inotropic support in cardiac surgery. Am J Surg 188:474-80.
11. Menasche P, Subayi JB, Veyssie L, et al. 1991. Efficacy of coronary sinus cardioplegia in patients with complete coronary artery occlusions. Ann Thorac Surg 151:418-23.
12. Nakayama A, del Monte F, Hajjar RJ, Frangioni JV. 2002. Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol Imaging 1:365-77.
13. Ntziachristos V, Bremer C, Weissleder R. 2003. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13:195-208.
14. Partington MT, Acar C, Buckberg GD, Julia PL. 1989. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium. J Thorac Cardiovasc Surg 97:613-22.
15. Soltesz EG, Kim S, Laurence RG, et al. 2005. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg 79:269-77; discussion 269-77.
16. Takaba T, Inoue K. 2000. Past and present in myocardial protection. Ann Thorac Cardiovasc Surg 6:3-8.
17. Takahashi A, Chambers DJ, Braimbridge MV, Hearse DJ. 1988. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. J Thorac Cardiovasc Surg 96:730-40.
18. Vogt PR, Bauer EP, Graves K. 2003. Novadaq Spy Intraoperative Imaging System - current status. Thorac Cardiovasc Surg 51:49-51.
19. Winkelmann J, Aronson S, Young CJ, et al. 1995. Retrograde-delivered cardioplegia is not distributed equally to the right ventricular free wall and septum. J Cardiothorac Vasc Anesth 9:135-9.
20. Zaroff J, Aronson S, Lee BK, et al. 1994. The relationship between immediate outcome after cardiac surgery, homogeneous cardioplegia delivery, and ejection fraction. Chest 106:38-45.